162 related articles for article (PubMed ID: 10482983)
21. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.
Gong J; Bhatia U; Traganos F; Darzynkiewicz Z
Leukemia; 1995 May; 9(5):893-9. PubMed ID: 7769853
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies.
Taniguchi T; Fujita A; Takahashi S; Uchimaru K; Yoshikawa M; Asano S; Fujita T; Motokura T
Jpn J Cancer Res; 1998 Feb; 89(2):159-66. PubMed ID: 9548443
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies to mammalian D-type G1 cyclins.
Vallance SJ; Lee HM; Roussel MF; Shurtleff SA; Kato JY; Strom DK; Sherr CJ
Hybridoma; 1994 Feb; 13(1):37-44. PubMed ID: 8200657
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclin genes in human gastric cancer and in first degree relatives.
Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E
Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540
[TBL] [Abstract][Full Text] [Related]
25. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
26. Mouse development and cell proliferation in the absence of D-cyclins.
Kozar K; Ciemerych MA; Rebel VI; Shigematsu H; Zagozdzon A; Sicinska E; Geng Y; Yu Q; Bhattacharya S; Bronson RT; Akashi K; Sicinski P
Cell; 2004 Aug; 118(4):477-91. PubMed ID: 15315760
[TBL] [Abstract][Full Text] [Related]
27. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia.
Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D
Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687
[TBL] [Abstract][Full Text] [Related]
28. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.
Mermelshtein A; Gerson A; Walfisch S; Delgado B; Shechter-Maor G; Delgado J; Fich A; Gheber L
Br J Cancer; 2005 Aug; 93(3):338-45. PubMed ID: 16012517
[TBL] [Abstract][Full Text] [Related]
29. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis.
Belsõ N; Széll M; Pivarcsi A; Kis K; Kormos B; Kenderessy AS; Dobozy A; Kemény L; Bata-Csörgõ Z
J Invest Dermatol; 2008 Mar; 128(3):634-42. PubMed ID: 17882269
[TBL] [Abstract][Full Text] [Related]
31. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
32. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation.
Wianny F; Real FX; Mummery CL; Van Rooijen M; Lahti J; Samarut J; Savatier P
Dev Dyn; 1998 May; 212(1):49-62. PubMed ID: 9603423
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo.
Sun W; Lee DK; Lee CC; Kim K
Mol Reprod Dev; 1996 Apr; 43(4):414-20. PubMed ID: 9052931
[TBL] [Abstract][Full Text] [Related]
35. Expression of cyclins D-type in B-chronic lymphoproliferative disorders.
Sola B; Roué G; Duquesne F; Avet-Loiseau H; Macro M; Salaün V; Troussard X
Leukemia; 2000 Jul; 14(7):1318-9. PubMed ID: 10914560
[No Abstract] [Full Text] [Related]
36. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
37. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
Geum D; Sun W; Paik SK; Lee CC; Kim K
Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
[TBL] [Abstract][Full Text] [Related]
38. Cyproheptadine displays preclinical activity in myeloma and leukemia.
Mao X; Liang SB; Hurren R; Gronda M; Chow S; Xu GW; Wang X; Beheshti Zavareh R; Jamal N; Messner H; Hedley DW; Datti A; Wrana JL; Zhu Y; Shi CX; Lee K; Tiedemann R; Trudel S; Stewart AK; Schimmer AD
Blood; 2008 Aug; 112(3):760-9. PubMed ID: 18502826
[TBL] [Abstract][Full Text] [Related]
39. Induction and expression of cyclin D3 in human pancreatic cancer.
Ebert MP; Hernberg S; Fei G; Sokolowski A; Schulz HU; Lippert H; Malfertheiner P
J Cancer Res Clin Oncol; 2001 Jul; 127(7):449-54. PubMed ID: 11469683
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
Dey A; Li W
Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
